NORTHERN TRUST CORP - ADURO BIOTECH INC ownership

ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 94 filers reported holding ADURO BIOTECH INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of ADURO BIOTECH INC
ValueSharesWeighting
Q3 2020$1,671,000
-4.2%
687,838
-8.9%
0.00%
Q2 2020$1,744,000
-12.3%
754,814
+4.0%
0.00%
-100.0%
Q1 2020$1,988,000
+152.9%
725,622
+9.0%
0.00%
Q4 2019$786,000
+1.4%
665,812
-8.9%
0.00%
Q3 2019$775,000
-33.8%
730,711
-3.8%
0.00%
Q2 2019$1,171,000
-60.7%
759,916
+1.6%
0.00%
-100.0%
Q1 2019$2,976,000
+55.8%
747,783
+3.4%
0.00%0.0%
Q4 2018$1,910,000
-65.4%
723,509
-3.6%
0.00%0.0%
Q3 2018$5,514,000
+13.2%
750,227
+7.8%
0.00%0.0%
Q2 2018$4,871,000
+11.1%
695,702
+47.6%
0.00%0.0%
Q1 2018$4,383,000
+23.2%
471,325
-0.7%
0.00%0.0%
Q4 2017$3,559,000
-29.0%
474,509
+0.8%
0.00%0.0%
Q3 2017$5,016,000
-2.9%
470,936
+3.9%
0.00%0.0%
Q2 2017$5,166,000
+22.1%
453,115
+15.1%
0.00%0.0%
Q1 2017$4,232,000
-4.9%
393,625
+0.9%
0.00%0.0%
Q4 2016$4,449,000
-4.8%
390,232
+3.8%
0.00%0.0%
Q3 2016$4,673,000
+20.5%
375,978
+9.7%
0.00%0.0%
Q2 2016$3,877,000
+226.1%
342,853
+269.6%
0.00%
Q1 2016$1,189,000
-52.8%
92,774
+3.7%
0.00%
-100.0%
Q4 2015$2,517,000
+54.0%
89,424
+6.0%
0.00%0.0%
Q3 2015$1,634,000
+232.8%
84,345
+420.6%
0.00%
Q2 2015$491,00016,2020.00%
Other shareholders
ADURO BIOTECH INC shareholders Q2 2020
NameSharesValueWeighting ↓
Foresite Capital Management II, LLC 1,656,994$46,628,00015.63%
Marquette Asset Management, LLC 350,000$9,849,0004.01%
Rock Springs Capital Management LP 415,000$11,678,0000.88%
OAK RIDGE INVESTMENTS LLC 835,837$23,520,0000.56%
SPHERA FUNDS MANAGEMENT LTD. 120,000$3,377,0000.49%
CLOUGH CAPITAL PARTNERS L P 257,837$7,256,0000.34%
NJ State Employees Deferred Compensation Plan 53,300$1,500,0000.31%
Spark Investment Management LLC 77,400$2,178,0000.28%
GLOBEFLEX CAPITAL L P 30,400$855,0000.23%
AHL Partners LLP 67,650$1,904,0000.15%
View complete list of ADURO BIOTECH INC shareholders